Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
STRATEGIC PARTNERS A/S
No one on the platform currently holds OZYMF.
No tracked institution reports a position in OZYMF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-12-06 | 1-for-1000reverse |
No one on the platform has traded OZYMF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Big updates for #Orphazyme investors! Settlement distribution is underway, with an average payout of $760 so far. Make sure to check your email if you filed with @11thestate! $ORPH $OZYMF
View on StockTwits ↗$ORPH $OZYMF settles for $2.5 million with investors to resolve claims regarding misleading statements made during its 2020 IPO. And you can still file for it. #Orphazyme #ORPH Case page:https://11thestate.com/cases/orphazyme-ipo-settlement "The Complaint alleges Offering Documents were negligently prepared and contained untrue statements. Defendants made false/misleading statements about arimoclomol's effectiveness and FDA approval prospects. This resulted in materially false public statements."
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| OZYMFStrategic Partners A/S | $90.00 | +0.00% | $4M | — |
| EVLOEvelo Biosciences, Inc. | $0.00 | +0.00% | $1898 | — |
| HLUNHEALTHeUNIVERSE, Inc. | $0.00 | +0.00% | $11778 | — |
| NNLXNanoLogix, Inc. | $0.00 | +0.00% | $9569 | — |
| PXMDPaxMedica, Inc. Common Stock | $0.00 | +0.00% | $63132 | — |
| QBIOQ BioMed Inc. | $0.00 | -0.00% | $14509 | — |
| SDCCQSmileDirectClub Inc Class A | $0.00 | +0.00% | $13395 | — |
Source: Financial Modeling Prep · peers by sector/industry